We observed that FGF-2 treatment of serum-starved GIST cells increased IC50 values for Dox and Eto (1.5 and 2.4-fold, respectively), thereby revealing the importance of FGF-signaling in the survival of GIST cells treated with topoisomerase II inhibitors. This evidence concerns the gene FGF2 and gastrointestinal stromal tumor.